Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02223754 · ClinicalTrials.gov registry record · NA
Evaluation of an Investigational Multifocal Lens
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 371
- Enrollment target
NCT02223754: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT02223754 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 371 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02223754, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 371 participants
- Enrollment target
Study Summary
The purpose of this study is to test the performance of an investigational multifocal test soft contact lens.
Primary Outcome
CLUE Overall Quality of Vision is assessed using the Contact Lens User Experience (CLUE)TM questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. 97% of t
Interventions
- DEVICE lotrafilcon B
- DEVICE etafilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2014-08 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT02223754 record still lists
NCT02223754 is an interventional study that assigns participants to a tested intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which lotrafilcon B is the first listed.
NCT02223754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02223754 about?
NCT02223754 is a clinical study titled "Evaluation of an Investigational Multifocal Lens". The purpose of this study is to test the performance of an investigational multifocal test soft contact lens.
What is the current status of trial NCT02223754?
This trial is currently completed. It is a NA study. The enrollment target is 371 participants. The study started on 2014-08. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02223754?
The interventions under investigation include: lotrafilcon B (DEVICE), etafilcon A (DEVICE).
Who is sponsoring clinical trial NCT02223754?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02223754's enrollment target sits among peer trials
371 281st of 2000 higher than 1,720 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia